Inactive Instrument
Invitae Corporation Stock Mexican S.E.
Stocks
NVTA *
US46185L1035
Biotechnology & Medical Research
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Spirito
CEO | Chief Executive Officer | - | - |
Hoki Luk
IRC | Investor Relations Contact | - | - |
Robert Guigley
PRN | Corporate Officer/Principal | - | 2023-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -8.09% | - | - | 85.95K | ||
| -0.20% | +4.01% | +106.91% | +309.00% | 4.07B | ||
| +12.52% | +37.88% | +255.34% | +48.11% | 3.62B | ||
| -0.95% | -1.90% | +41.71% | +68.58% | 3.39B | ||
| +1.03% | -0.82% | +286.11% | +458.74% | 2.41B | ||
| +16.44% | +4.39% | -15.09% | -18.97% | 2.14B | ||
| -0.88% | +16.37% | +27.81% | - | 1.54B | ||
| +14.82% | +43.43% | +236.99% | -18.00% | 1.08B | ||
| +4.17% | -2.04% | +17.04% | +49.52% | 983M | ||
| +4.25% | -0.30% | -33.83% | -1.04% | 544M | ||
| Average | +5.12% | +11.67% | +102.56% | +111.99% | 2.2B | |
| Weighted average by Cap. | +5.06% | +11.74% | +124.06% | +151.15% |
Employees
1,700
















